Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: An in vivo electrochemical study

Brain Research

Volumn 1407, Issue , 2011, Pages 27-37

  Crespi, Francesco ^a  

^a GSK   (Italy)

Author keywords

5 OH indole; Antidepressant; Catechol; Neuropeptide Y; Peptide; Rat amygdala; Voltammetry in vitro and in vivo

Indexed keywords

5 OH INDOLE; ANTIDEPRESSANT AGENT; BRAIN MONOAMINE; CARBON FIBER; CATECHOL; FLUOXETINE; IMIPRAMINE; INDOLE; INDOLE DERIVATIVE; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE Y; PARGYLINE; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CATECHOLAMINERGIC SYSTEM; CEREBROSPINAL FLUID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEPRESSION; DIFFERENTIAL PULSE VOLTAMMETRY; DRUG ACTIVITY; ELECTROCHEMISTRY; IN VIVO STUDY; MALE; MICROELECTRODE; NONHUMAN; OXIDATION KINETICS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SEROTONINERGIC SYSTEM;

AMYGDALA; ANIMALS; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANXIETY; ARGININE; BIOGENIC MONOAMINES; BIOSENSING TECHNIQUES; BRAIN CHEMISTRY; CATECHOLAMINES; DEPRESSION; ELECTROCHEMISTRY; FLUOXETINE; IMIPRAMINE; INDOLES; MALE; NEUROPEPTIDE Y; NEUROPEPTIDES; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; SEROTONIN UPTAKE INHIBITORS;

RATTUS; RODENTIA;

EID: 79960987009     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.05.033     Document Type: Article

References (45)

1. Aicher, S.A., Springston, M., Berger, S.B., Reis, D.I., Wahlestedt, C., 1991. Receptor-selective analogs demonstrate NPY/PYY receptor heterogeneity in rat brain. Neurosci. Lett. 130, 32-36.
2. Blomqvist, A.G., Herzog, H., 1997. Y-receptor subtypes - how many more? Trends Neurosci. 20, 294-298.
3. Britton, K.T., Southerland, S.,VanUden, E., Kirby,D., River, J., Koob,G., 1997. Anxiolytic activity of NPY receptor agonist in the conflict test. Psychopharmacology 132, 6-16.
4. Crespi, F., 1990. In vivo voltammetry with microbiosensors for analysis of neurotransmitter release and metabolism J. Neurosci. Methods 34, 53-65.
5. Crespi, F., 2002. In vivo voltammetry and concomitant electrophysiology at a single biosensor to analyse ischaemia, depression and drug dependence. Journal of Neuroscience Methods 119, 173-184.
6. Crespi, F., 2010. The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity? Neurosci. Lett. 470, 95-99.
7. Crespi, F., Rossetti, Z., 2004. Pulse of nitric oxide release in response to activation of N-methyl-D-aspartate receptors in the rat striatum: rapid desensitisation, inhibition by receptor antagonists and potentiation by glycine. J. Pharmacol. Exp. Ther. 309, 462-468.
8. Dale, S.D., 1995. Neuropeptide Y: a promising therapeutic target. Review. Exp. Opin. Ther. Patents. 5, 391-396.
9. De Quidt, M.E., Emson, P.C., 1986. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system. II. Immunohistochemical analysis. Neuroscience 18, 545-618.
10. Dryden, S., Frankish, R., Wang, Q., Pickavance, L., Williams, G., 1996. The serotonergic agent fluoxetine reduces NPY levels and secretion in the hypothalamus of lean and obese rats. Neuroscience 72, 557-566.
11. Dumont, Y., Fourner, A., St-Pierre, S., Schwartz, T.W., Quirion, R., 1990. Differential distribution of Neuropeptide Y1 and Y2 receptors in the rat brain. Eur. J. Pharmacol. 191, 501-503.
12. Gregor, P., Feng, Y., Decarr, L.B., Cornfield, L.J., McCaleb, M.L., 1996. Molecular characterization of a second mouse pancreatic polypeptide receptor and its inactivated human homologue J. Biol. Chem. 271, 27776-27781.
13. Grundermar, L., 1995. Will neuropeptide Y receptor antagonist offer new therapeutic approaches? Exp. Opin. Patents. 5, 1007-1013.
14. Heilig, M., Wahlestedt, C., Ekman, R., Widerlov, E., 1988. Antidepressant drugs increase the concentrations of neuropeptide Y (NPY)-like immunoreactivity in the rat brain. Eur. J. Pharmacol. 147, 465-467.
15. Heilig, M., 1993. Neuropeptide Y in relation to behaviour and psychiatric disorders. In: Colmers, W.F., Wahlestedt, C. (Eds.), The Biology of Neuropeptide Y and Related Peptides. Humana Press. Inc, Totowa, N.J, pp. 511-554.
16. Heilig, M., Ekman, R., 1995. Chronic parenteral antidepressant treatments in rats: unaltered levels and processing of NPY and CRH. Neurochem. International 26 (4), 351-355.
17. Kalra, S.P., Sahu, A., Crowleg, W.R., 1990. Hypothalamic neuropeptide Y: a circuit in the regulation of gonadotropin secretion and feeding behavior. Ann. NY Acad. Sci. 611, 273-283.
18. Koide, S., Onishi, H., Hashimoto, H., Kai, T., Katayama, M., Yamagami, S., 1995. Effects of bifemelane hydrochloride on plasma neuropeptide Y, 3-methoxy-4-hydroxyphenylethylene glycol and 5-hydroxy-indole acetic acid concentrations in patients with cerebral infarction. Drugs under Exp. Clin. Res. 21, 175-180.
19. Kruk, Z., Pycock, C., 1993. Neurotransmitters and drugs, Croom Helm Biology in Medicine Series, Second Edition, pp. 61-62.
20. Lazzarini, C., Vecchiato, E., Crespi, F., 2002. Influence of fluoxetine on extracellular levels of serotonin in rat brain regions: an in vivo concomitant electrochemical and electrophysiological study. British Journal of Pharmacology 135S, 359P.
21. Lundeberg, J.M., Terenius, L., Hokfelt, T., Martling, C.R., Tatemoto, K., Mutt, V., Polak, J., Bloom, S., Goldstein, M., 1982. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol. Scand. 116, 477-790.
22. Mathé, A.A., Husum, H., Khoury, A.E., Jiménez-Vasquez, P., Gruber, S.H.M., Wörtwein, G., Angelucci, F., 2007. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol. Behav. 92 (1-2), 226-231.
23. Matsumoto, M., Nomura, T., Momose, K., Ikeda, Y., Kondou, Y., Akiho, H., Togami, J., Kimura, Y., Okada, M., Yamaguchi, T., 1996. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J. Biol. Chem. 271, 27217-27220.
24. Michel, M.C., Rascher, W., 1995. Neuropeptide Y: a possible role in hypertension? J. Hypertension 13, 385-395.
25. Munglani, R., Hudspith, M.J., Hunt, S.P., 1996. The therapeutic potential of NPY. Drugs 52 (3), 371-389.
26. Nemeroff, C.B., Bissette, G., Akil, R., Fink, M., 1991. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with elettroconvulsive therapy, corticotrophin-releasing factor, (3-endorphin and somatostatin. Br. J. Psychiatry 158, 59-63.
27. Nielsen, S., Sheikh, S.P., Christensen, E.I., 1991. Axial heterogeneity of peptide YY processing in renal proximal tubules Am. J. Physiol. 260, 359-367.
28. Norman, T.R., 2006. Prospects for the treatment of depression. Australian and New Zealand Journal of Psychiatry 40, 394-401.
29. Overstreet, D.H., Friedman, E., Mathé, A.A., Yadid, G.G., 2005. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 29, 739-759.
30. Pacher, P., Kecskemeti, V., 2004. Trends in the development of new antidepressants. Is there a light at the end of the tunnel? Current Medicinal Chemistry 11, 925-943.
31. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, London.
32. Pozzi, L., Invernizzi, R., Garavaglia, C., Samanin, R., 1997. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. J. Neurochem. 73, 1051-1057. (Pubitemid 29395461)
33. Redrobe, J.P., Dumont, Y., Quirion, R., 2002. Neuropeptide Y (NPY) and depression: from animal studies to the human condition. Life Sci. 71 (25), 2921-2937. (Pubitemid 35221402)
34. Romero, L., Casanova, J., Hervas, I., Cortes, R., Artigas, F., 1997. Strategies to optimize the antidepressant action of selective serotonin reuptake inhibitors. In: Skolnick, P. (Ed.), Antidepressants: Current Trends and Future Directions. Humana Press, Totowa, pp. 1-33.
35. Rudolf, K.W., Eberlein, W., Engel, H.A., Wieland, K.D., Willim, M., Entzeroth, W., Wienen, A.G., Beck-Sickinger, H., Doods, N., 1994. The first highly potent and selective non-peptide neuropeptide Y Yl receptor antagonist: BffiP3226 European J. Pharmacology 271, 11-13.
36. Stamford, J.A., Crespi, F., Marsden, C.A., 1992. In vivo voltammetric methods for monitoring monoamine release and metabolism. In: Stamford, J. (Ed.), Monitoring Neuronal Activity. A practical approach: The Practical Approach Series. Oxford University Press, UK, pp. 113-145.
37. Stanley, B.G., Leibowitz, S.F., 1985. Neuropeptide Y injected into the paraventricular nucleus; a powerful stimulant of feeding behaviour. Proc. Natl. Acad. Sci. USA 82, 3940-3943.
38. Stenfors, C., Hellman, U., Silberring, J., 1997. Characterization of endogenous neuropeptide Y in rat hippocampus and its metabolism by nanospray mass spectrometry. J. Biol. Chem. 272, 5747-5751.
39. Stogner, K.A., Holmes, P.V., 2000. Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats Eur J. Pharmacol. 387 (2), R9-R10. (Pubitemid 30067822)
40. Tatemoto, K., Ohara, M.T., Schwartz, T.W., 1989. Binding of monoiodinated Neuropeptide Y to Hippocampal membranes and human neuroblastoma cell lines. J. BioI. Chern. 264, 6648-6654.
41. Wahlestedt, C., Edvinsson, L., Ekblad, E., Hakanson, R., 1985. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction: mode of action. J. Pharmacol. Exp. Ther. 234, 735-741.
42. Wahlestedt, C., Blendy, J.A., Kellar, K.J., Heilig, M., Widerlov, E., Ekman, R., 1990. Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat. Brain Res. 59, 73-80.
43. Weinberg, D.H., Sirinatsinghji, D.J.S., Tan, C.P., Shiao, L.L., Morin, N., Rigby, M.R., Heavens, R.H., Rapoport, D.R., Bayne, M.I., Cascieri, M.A., Strader, C.D., Linemeyer, D.L., MacNeil, D.J., 1996. Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem. 271, 16485-16488.
44. Widdowson, P., Ordway, G.A., Halaris, A.E., 1992. Reduced NPY concentrations in suicide brain. J Neurochem. 59 (1), 73-80.
45. Zukowska-Grojec, Z., 1997. Neuropeptide Y: implications in vascular remodeling. Drug News Perspect. 10, 587-595.